Table 1.
Patient demographics
| Pregabalin (n = 72) | Placebo (n = 80) | |
|---|---|---|
| Gender, n (%) | ||
| Male | 36 (50.0) | 39 (48.8) |
| Female | 36 (50.0) | 41 (51.3) |
| Mean age ± SD, years | 58.2 ± 11.3 | 59.9 ± 11.9 |
| Age, years, n (%) | ||
| 18–44 | 7 (9.7) | 7 (8.8) |
| 45–64 | 43 (59.7) | 47 (58.8) |
| ≥65 | 22 (30.6) | 26 (32.5) |
| Race, n (%) | ||
| White | 44 (61.1) | 47 (58.8) |
| Black | 2 (2.8) | 2 (2.5) |
| Asian | 17 (23.6) | 19 (23.8) |
| Other | 9 (12.5) | 12 (15.0) |
| Mean weight ± SD, kg | 67.1 ± 16.4 | 68.1 ± 17.5 |
| Mean height ± SD, cm | 165.4 ± 10.9 | 163.3 ± 9.9 |
| Mean duration since diagnosis of metastatic pain, years (range) | 0.9 (0–5.4) | 1.4 (0–16.3) |
SD standard deviation